Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland
Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland
复制标题
DOI：
10.1111/j.1528-1167.2009.02417.x
复制
发表时间：
2010-05-01
期刊：
影响因子：
5.6
通讯作者：
Glynn, Mike
中科院分区：
文献类型：
--
作者：
Linehan, Christine;Kerr, Mike P.;Glynn, Mike
目的：调查爱尔兰癫痫的患病率和癫痫护理的提供情况。方法：采用多病例确定方法检查五个全国数据源。数据通过以下途径获得：(1) 全国范围内的人口健康调查；(2) 对 2002 年至 2005 年全国范围内所有抗癫痫药物处方报销进行的二次数据分析；(3) 对初级保健社区医生进行的全国范围调查；(4) 对专科护理医院神经科医生进行的全国范围调查；(5) 对 2000 年至 2005 年期间全国急性医院住院患者出院情况进行的二次数据分析。 2005. 结果：调查结果表明，全国范围内，大约 (1) 18 岁及以上每 1,000 人（n = 31,000）中有 10 人自我报告癫痫终生患病率，(2) 5 岁及以上每 1,000 人（约 33,000-36,000）中有 8.3-9 人正在接受抗癫痫药物治疗， (3) 典型的全科医生平均为 13 名活动性癫痫患者和经治疗缓解的癫痫患者提供护理，(4) 每周为约 442 名活动性癫痫患者和经治疗缓解的癫痫患者提供专科护理，(5) 每周从急性医院报告约 67 名初次或二次诊断为癫痫的患者出院。 讨论：本研究是欧洲第一项全国范围的癫痫患病率研究，并提供了以前无法获得的信息有关爱尔兰人口的数据。此外，本研究说明了当用于识别流行病学样本的临床来源受到限制时，对现有来源进行二次数据分析的优点。
Purpose:To examine the prevalence of epilepsy and delivery of epilepsy care in Ireland.Methods:A multiple case ascertainment methodology was employed examining five nationwide data sources. Data were obtained via (1) a nationwide population-based health survey, (2) secondary data analysis of all reimbursements for prescriptions of antiepilepsy medication nationwide from 2002 to 2005, (3) a nationwide survey of primary care community-based physicians, (4) a nationwide survey of specialist care hospital-based neurologists, and (5) secondary data analysis of inpatient discharges from acute hospitals nationwide for persons with a diagnosis of epilepsy between 2000 and 2005.Results:The findings indicate that nationwide approximately (1) 10 per 1,000 persons (n = 31,000) 18 years and older have self-reported lifetime prevalence of epilepsy, (2) 8.3-9 per 1,000 (approximately 33,000-36,000) persons 5 years and older are being treated for epilepsy using antiepilepsy medication, (3) the typical general practitioner provides care to an average of 13 patients with active epilepsy and epilepsy in remission with treatment, (4) specialist care is provided on a weekly basis to approximately 442 persons with active epilepsy and epilepsy in remission with treatment, and (5) approximately 67 discharges for persons with a primary or secondary diagnosis of epilepsy are reported from acute hospitals weekly.Discussion:This study is distinguished as the first nationwide prevalence study of epilepsy in Europe and provides previously unavailable data on this population in Ireland. Moreover, this study illustrates the merits of secondary data analysis of existing sources when access to clinical sources for the purpose of identifying epidemiologic samples is limited.